Literature DB >> 32217556

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.

Tao Chen1, Di Wu1, Huilong Chen1, Weiming Yan1, Danlei Yang2, Guang Chen1, Ke Ma1, Dong Xu1, Haijing Yu1, Hongwu Wang1, Tao Wang2, Wei Guo1, Jia Chen1, Chen Ding1, Xiaoping Zhang1, Jiaquan Huang1, Meifang Han1, Shusheng Li3, Xiaoping Luo4, Jianping Zhao2, Qin Ning5.   

Abstract

OBJECTIVE: To delineate the clinical characteristics of patients with coronavirus disease 2019 (covid-19) who died.
DESIGN: Retrospective case series.
SETTING: Tongji Hospital in Wuhan, China. PARTICIPANTS: Among a cohort of 799 patients, 113 who died and 161 who recovered with a diagnosis of covid-19 were analysed. Data were collected until 28 February 2020. MAIN OUTCOME MEASURES: Clinical characteristics and laboratory findings were obtained from electronic medical records with data collection forms.
RESULTS: The median age of deceased patients (68 years) was significantly older than recovered patients (51 years). Male sex was more predominant in deceased patients (83; 73%) than in recovered patients (88; 55%). Chronic hypertension and other cardiovascular comorbidities were more frequent among deceased patients (54 (48%) and 16 (14%)) than recovered patients (39 (24%) and 7 (4%)). Dyspnoea, chest tightness, and disorder of consciousness were more common in deceased patients (70 (62%), 55 (49%), and 25 (22%)) than in recovered patients (50 (31%), 48 (30%), and 1 (1%)). The median time from disease onset to death in deceased patients was 16 (interquartile range 12.0-20.0) days. Leukocytosis was present in 56 (50%) patients who died and 6 (4%) who recovered, and lymphopenia was present in 103 (91%) and 76 (47%) respectively. Concentrations of alanine aminotransferase, aspartate aminotransferase, creatinine, creatine kinase, lactate dehydrogenase, cardiac troponin I, N-terminal pro-brain natriuretic peptide, and D-dimer were markedly higher in deceased patients than in recovered patients. Common complications observed more frequently in deceased patients included acute respiratory distress syndrome (113; 100%), type I respiratory failure (18/35; 51%), sepsis (113; 100%), acute cardiac injury (72/94; 77%), heart failure (41/83; 49%), alkalosis (14/35; 40%), hyperkalaemia (42; 37%), acute kidney injury (28; 25%), and hypoxic encephalopathy (23; 20%). Patients with cardiovascular comorbidity were more likely to develop cardiac complications. Regardless of history of cardiovascular disease, acute cardiac injury and heart failure were more common in deceased patients.
CONCLUSION: Severe acute respiratory syndrome coronavirus 2 infection can cause both pulmonary and systemic inflammation, leading to multi-organ dysfunction in patients at high risk. Acute respiratory distress syndrome and respiratory failure, sepsis, acute cardiac injury, and heart failure were the most common critical complications during exacerbation of covid-19. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Year:  2020        PMID: 32217556     DOI: 10.1136/bmj.m1091

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  1305 in total

Review 1.  Coronavirus Disease 2019 (COVID-19) From the Point of View of Neurologists: Observation of Neurological Findings and Symptoms During the Combat Against a Pandemic.

Authors:  Ayşe Nur Özdağ Acarli; Bedia Samanci; Esme Ekizoğlu; Arman Çakar; Nermin Görkem Şirin; Tuncay Gündüz; Yeşim Parman; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2020-05-01       Impact factor: 1.339

2.  Subacute stent thrombosis in a patient with COVID-19 pneumonia.

Authors:  Mohamed Ayan; Swathi Kovelamudi; Malek Al-Hawwas
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-09-08

3.  Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19).

Authors:  Giuseppe Lippi; Johnny Wong; Brandon Michael Henry
Journal:  World J Emerg Med       Date:  2020

4.  Pre-existing cardiovascular disease, acute kidney injury, and cardiovascular outcomes in hospitalized blacks with COVID-19 infection.

Authors:  Obiora Egbuche; Opeyemi Jegede; Temidayo Abe; Bivek Wagle; Ky Huynh; Dolphurs Hayes; Martin Luther Campbell; Kenechukwu Mezue; Pradhum Ram; Shirley I Nwokike; Rupak Desai; Valery Effoe; Jacques Kpodonu; Jayne Morgan; Elizabeth Ofili; Anekwe Onwuanyi; Melvin R Echols
Journal:  Am J Cardiovasc Dis       Date:  2021-04-15

Review 5.  Cardiovascular Complications of COVID-19 and Associated Concerns: A Review.

Authors:  Wen-Liang Yu; Han Siong Toh; Chia-Te Liao; Wei-Ting Chang
Journal:  Acta Cardiol Sin       Date:  2021-01       Impact factor: 2.672

6.  SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists.

Authors:  Luca Giovanella; Rosaria M Ruggeri; Petra Petranović Ovčariček; Alfredo Campenni; Giorgio Treglia; Desiree Deandreis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06       Impact factor: 9.236

7.  AKI in Hospitalized Patients with and without COVID-19: A Comparison Study.

Authors:  Molly Fisher; Joel Neugarten; Eran Bellin; Milagros Yunes; Lindsay Stahl; Tanya S Johns; Matthew K Abramowitz; Rebecca Levy; Neelja Kumar; Michele H Mokrzycki; Maria Coco; Mary Dominguez; Kalyan Prudhvi; Ladan Golestaneh
Journal:  J Am Soc Nephrol       Date:  2020-07-15       Impact factor: 10.121

8.  COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.

Authors:  Purva Sharma; Nupur N Uppal; Rimda Wanchoo; Hitesh H Shah; Yihe Yang; Rushang Parikh; Yuriy Khanin; Varun Madireddy; Christopher P Larsen; Kenar D Jhaveri; Vanesa Bijol
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

9.  COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm?

Authors:  C Rasmussen; I Niculescu; S Patel; A Krishnan
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

Review 10.  SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.

Authors:  Kiandokht Keyhanian; Raffaella Pizzolato Umeton; Babak Mohit; Vahid Davoudi; Fatemeh Hajighasemi; Mehdi Ghasemi
Journal:  J Neuroimmunol       Date:  2020-11-07       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.